MZMichael E. Zalis

Michael E. Zalis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael E. Zalis has a total of 93 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • How I Do It: Bringing Together a Multidisciplinary Radiology Green Team

    by Benjamin E. Northrup, Maura J. Brown, Andrew M. Hernandez, Andrea G. Rockall, Michael E. Zalis, Kate Hanneman

    This article provides a structured, stepwise, practical framework for forming a multidisciplinary Radiology Green Team to coordinate, implement, and measure results to advance sustainable imaging practices.

  • CT Colonography Reporting and Data System (C-RADS): Version 2023 Update

    by Judy Yee, Abraham Dachman, David Kim, Mariya Kobi, Andrea Laghi, Elizabeth McFarland, Courtney Moreno, Seong Ho Park, Perry Pickhardt, Andrew Plumb, et al.

    The CT Colonography Reporting and Data System (C-RADS) has withstood the test of time and proven to be a robust classification scheme for CT colonography (CTC) findings. C-RADS version 2023 represents an update on the scheme used for colorectal and extracolonic findings at CTC. The update provides useful insights gained since the implementation of the original system in 2005. Increased experience has demonstrated confusion on how to classify the mass-like appearance of the colon consisting of soft tissue attenuation that occurs in segments with acute or chronic diverticulitis. Therefore, the update introduces a new subcategory, C2b, specifically for mass-like diverticular strictures, which are likely benign. Additionally, the update simplifies extracolonic classification by combining E1 and E2 categories into an updated extracolonic category of E1/E2 since, irrespective of whether a finding is considered a normal variant (category E1) or an otherwise clinically unimportant finding (category E2), no additional follow-up is required. This simplifies and streamlines the classification into one category, which results in the same management recommendation.


  • CT colonography’s role in the COVID-19 pandemic: a safe(r), socially distanced total colon examination

    by Courtney C. Moreno, Judy Yee, Firas S. Ahmed, Matthew A. Barish, Cecelia Brewington, Abraham H. Dachman, Marc J. Gollub, David H. Kim, Elizabeth McFarland, Perry J. Pickhardt, et al.

    Purpose To describe the favorable procedural profile of CT colonography (CTC) during the COVID-19 pandemic. Conclusion Postponement of cancer screening due to COVID-19 has resulted in a backlog of individuals needing to undergo structural examination of the colon. The experience during the initial COVID-19 surge with urgent evaluation of the colon for transplant patients prior to transplant suggests that CTC can be done in a lower risk manner as compared to other structural examinations. The procedural profile of CTC is advantageous during this pandemic as maintaining social distancing and preserving healthcare supplies including PPE are of paramount importance. CTC is an important option to utilize in the screening armamentarium to allow effective screening of average risk asymptomatic individuals in the COVID-19 era.


  • Diagnostic Accuracy of Laxative-Free Computed Tomographic Colonography for Detection of Adenomatous Polyps in Asymptomatic Adults

    by Michael E. Zalis, Michael A. Blake, Wenli Cai, Peter F. Hahn, Elkan F. Halpern, Imrana G. Kazam, Myles Keroack, Cordula Magee, Janne J. Näppi, Rocio Perez-Johnston, et al.

    Colon screening by optical colonoscopy (OC) or computed tomographic colonography (CTC) requires a laxative bowel preparation, which inhibits screening participation. To assess the performance of detecting adenomas 6 mm or larger and patient experience of laxative-free, computer-aided CTC. Prospective test comparison of laxative-free CTC and OC. The CTC included electronic cleansing and computer-aided detection. Optical colonoscopy examinations were initially blinded to CTC results, which were subsequently revealed during colonoscope withdrawal; this method permitted reexamination to resolve discrepant findings. Unblinded OC served as a reference standard. (ClinicalTrials.gov registration number: NCT01200303) Multicenter ambulatory imaging and endoscopy centers. 605 adults aged 50 to 85 years at average to moderate risk for colon cancer. Per-patient sensitivity and specificity of CTC and first-pass OC for detecting adenomas at thresholds of 10 mm or greater, 8 mm or greater, and 6 mm or greater; per-lesion sensitivity and survey data describing patient experience with preparations and examinations. For adenomas 10 mm or larger, per-patient sensitivity of CTC was 0.91 (95% CI, 0.71 to 0.99) and specificity was 0.85 (CI, 0.82 to 0.88); sensitivity of OC was 0.95 (CI, 0.77 to 1.00) and specificity was 0.89 (CI, 0.86 to 0.91). Sensitivity of CTC was 0.70 (CI, 0.53 to 0.83) for adenomas 8 mm or larger and 0.59 (CI, 0.47 to 0.70) for those 6 mm or larger; sensitivity of OC for adenomas 8 mm or larger was 0.88 (CI, 0.73 to 0.96) and 0.76 (CI, 0.64 to 0.85) for those 6 mm or larger. The specificity of OC at the threshold of 8 mm or larger was 0.91 and at 6 mm or larger was 0.94. Specificity for OC was greater than that for CTC, which was 0.86 at the threshold of 8 mm or larger and 0.88 at 6 mm or larger (P= 0.02). Reported participant experience for comfort and difficulty of examination preparation was better with CTC than OC. There were 3 CTC readers. The survey instrument was not independently validated. Computed tomographic colonography was accurate in detecting adenomas 10 mm or larger but less so for smaller lesions. Patient experience was better with laxative-free CTC. These results suggest a possible role for laxative-free CTC as an alternate screening method.


  • 7 Imaging-Based Screening for Colorectal Cancer

    by James M. A. Slattery, Lucy E. Modahl, Michael E. Zalis

  • Patient Preparation and Tagging

    by Dipti K. Lenhart, Rocio Perez Johnston, Michael E. Zalis


  • Initial Observations of Electronic Medical Record Usage During CT and MRI Interpretation: Frequency of Use and Impact on Workflow

    by Abraham Lin, Mitchell Harris, Michael Zalis

    OBJECTIVE. Electronic medical record (EMR) systems permit integration of contextual nonimaging EMR data into examination interpretation; however, the extra effort required to search and review these nonradiologic data are not well characterized. We assessed the gross frequency and pattern of EMR usage in the interpretation of diagnostic CT and MRI examinations. SUBJECTS AND METHODS. We defined nonradiologic EMR data as laboratory data, nonimaging specialty report, clinical note, and administrative data not available on PACS. For abdominal, neuroradiologic, and musculoskeletal CT and MRI, we prospectively recorded the time required for image analysis (including prior imaging studies and their reports), nonradiologic EMR use, and initial report drafting by fellows and staff in randomized sessions. We assessed EMR use as a fraction of work activity and according to technique, subspecialty, inpatient status, and radiologist experience. RESULTS. We observed 372 CT and MRI interpretations by 33 radiologists. For CT, radiologists used the EMR in 34% of abdominal, 57% of neuroradiologic, and 38% of musculoskeletal interpretations. For MRI, EMR was used in 73% of abdominal, 56% of neuroradiologic, and 33% of musculoskeletal interpretations. For CT, EMR usage comprised 18%, 14%, and 18% of diagnostic effort (image analysis plus EMR use) for abdominal, neuroradiologic, and musculoskeletal interpretations, respectively; for MRI, EMR usage comprised 21%, 16%, and 15% of diagnostic effort for abdominal, neuroradiologic, and musculoskeletal interpretations, respectively. Frequency of EMR use was significantly greater for neuroradiology CT and abdominal MRI (p < 0.05, Fisher's test). EMR usage was not consistently related to inpatient status for CT or radiologist experience. CONCLUSION. For CT and MRI interpretation, EMR usage is frequent and comprises a significant fraction of diagnostic effort.


  • ACR Colon Cancer Committee White Paper: Status of CT Colonography 2009

    by Elizabeth G. McFarland, Joel G. Fletcher, Perry P. Pickhardt, Abraham Dachman, Judy Yee, Cynthia H. McCollough, Michael Macari, Paul Knechtges, Michael Zalis, Matthew Barish, et al.

    Purpose: To review the current status and rationale of the updated ACR practice guidelines for CT colonography (CTC). Methods: Clinical validation trials in both the U.S. and Europe are reviewed. Key technical aspects of the CTC examination are emphasized, including low-dose protocols, proper insufflation, and bowel preparation. Important issues of implementation are discussed, including training and certification, definition of target lesion, reporting of colonic and extracolonic findings, quality metrics, reimbursement, and cost-effectiveness. Results: Successful validation trials in screening cohorts both in the U.S. with ACRIN® and in Germany demonstrated sensitivity of 90% or greater for patients with polyps 10 mm or greater. Proper technique is critical, including low-dose techniques in screening cohorts with upper limits in CTDIvol of 12.5 mGy per exam. Training of new readers includes the requirement of interactive workstation training with 2-D and 3-D image display techniques. The target lesion is defined as a polyp 6 mm or greater, consistent with the American Cancer Society joint guidelines. Five quality metrics have been defined for CTC, with pilot data entered. Although the CMS national noncoverage decision in May 2009 was a disappointment, multiple third-party payers are reimbursing for screening CTC. Cost-effective modeling has shown CTC to be a dominant strategy, including in a Medicare cohort. Conclusion: Supported by third party payer reimbursement for screening, CTC will continue to further transition into community practice and can provide an important adjunctive examination for colorectal screening.